These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21130036

  • 1. Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
    Pierzynski P.
    Reprod Biomed Online; 2011 Jan; 22(1):9-16. PubMed ID: 21130036
    [Abstract] [Full Text] [Related]

  • 2. Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure.
    Lan VT, Khang VN, Nhu GH, Tuong HM.
    Reprod Biomed Online; 2012 Sep; 25(3):254-60. PubMed ID: 22818095
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM.
    BMC Pregnancy Childbirth; 2007 Jun 01; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [Abstract] [Full Text] [Related]

  • 5. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G.
    Prog Brain Res; 2008 Jun 01; 170():473-512. PubMed ID: 18655903
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF.
    Moraloglu O, Tonguc E, Var T, Zeyrek T, Batioglu S.
    Reprod Biomed Online; 2010 Sep 01; 21(3):338-43. PubMed ID: 20638340
    [Abstract] [Full Text] [Related]

  • 8. A randomized double blind comparison of atosiban in patients undergoing IVF treatment.
    Ng EH, Li RH, Chen L, Lan VT, Tuong HM, Quan S.
    Hum Reprod; 2014 Dec 01; 29(12):2687-94. PubMed ID: 25336707
    [Abstract] [Full Text] [Related]

  • 9. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M, Stoev S, Cheng LL, Wo NC, Chan WY.
    J Pept Sci; 2001 Sep 01; 7(9):449-65. PubMed ID: 11587184
    [Abstract] [Full Text] [Related]

  • 10. FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus.
    Nilsson L, Reinheimer T, Steinwall M, Akerlund M.
    BJOG; 2003 Nov 01; 110(11):1025-8. PubMed ID: 14592588
    [Abstract] [Full Text] [Related]

  • 11. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M, Cheng LL, Stoev S, Wo NC, Chan WY, Szeto HH, Durroux T, Mouillac B, Barberis C.
    J Pept Sci; 2005 Oct 01; 11(10):593-608. PubMed ID: 15880385
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin and oxytocin in normal reproduction and in the pathophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions.
    Akerlund M.
    Rocz Akad Med Bialymst; 2004 Oct 01; 49():18-21. PubMed ID: 15631309
    [Abstract] [Full Text] [Related]

  • 13. Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study.
    Chou PY, Wu MH, Pan HA, Hung KH, Chang FM.
    Taiwan J Obstet Gynecol; 2011 Jun 01; 50(2):136-40. PubMed ID: 21791296
    [Abstract] [Full Text] [Related]

  • 14. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M, Melin P, Maggi M.
    Adv Exp Med Biol; 1995 Jun 01; 395():595-600. PubMed ID: 8714023
    [Abstract] [Full Text] [Related]

  • 15. Oxytocin antagonists for the management of preterm birth: a review.
    Usta IM, Khalil A, Nassar AH.
    Am J Perinatol; 2011 Jun 01; 28(6):449-60. PubMed ID: 21170825
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
    Serradeil-Le Gal C, Valette G, Foulon L, Germain G, Advenier C, Naline E, Bardou M, Martinolle JP, Pouzet B, Raufaste D, Garcia C, Double-Cazanave E, Pauly M, Pascal M, Barbier A, Scatton B, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 2004 Apr 01; 309(1):414-24. PubMed ID: 14722330
    [Abstract] [Full Text] [Related]

  • 19. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON, Dorn C, van de Vondel P, Ulrich U, Schmolling J.
    Arch Gynecol Obstet; 2005 Jun 01; 272(1):26-30. PubMed ID: 15909190
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.